SIGA Technologies, Inc(NASDAQ:SIGA) 
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technolog...
Website: http://www.siga.com
Founded: 1995
Full Time Employees: 41
CEO: Phillip Gomez
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.97
H 5.42
L 4.95
C 5.39
V 487,481
10EMA 5.39
20EMA 5.39
60EMA 5.39
120EMA 5.39
250EMA 5.39